Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000842023-14-000014

Senior VP - Biotech sold 3,591 shares at an average $89.35 ($320,844)

  • Senior VP - Biotech acquired 3,591 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

REAGAN KEVIN J · Senior VP - Biotech

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2014-12-05 Exercise or conversion : show line 1 in the form +1,000 $70.96 $70,960 1,000 D
2014-12-05 Sale : show line 2 in the form −1,000 $89.41 $89,412 0 D
2014-12-09 Exercise or conversion : show line 3 in the form +2,591 $70.96 $183,857 2,591 D
2014-12-09 Sale : show line 4 in the form −2,591 $89.32 $231,432 0 D
Open-market sales · 3,591 sh · avg $89.35 · $320,844

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-12-05 Exercise or conversion : show line 5 in the form Stock Option −1,000 $70.96 2019-01-23 1,000 9,773 D
2014-12-09 Exercise or conversion : show line 6 in the form Stock Option −2,591 $70.96 2019-01-23 2,591 7,182 D
Loading xslF345X03/primary_doc.xml…